References
  1. Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO. Polycystic ovary syndrome. Nat Rev Dis Primers2016;2:16057.
  2. Jeanes YM, Reeves S. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenge. Nutr Res Rev 2017;30:97-105.
  3. Jiao J, Shi B, Wang T, Fang Y, Cao T, Zhou Y, Wang X, Li D. Characterization of long non-coding RNA and messenger RNA profiles in follicular fluid from mature and immature ovarian follicles of healthy women and women with polycystic ovary syndrome. Hum Reprod2018;33:1735-1748.
  4. Hannou SA, Haslam DE, McKeown NM, Herman MA. Fructose metabolism and metabolic disease. J Clin Invest 2018;128:545-555.
  5. Shi B, Feng D, Sagnelli M, Jiao J, Sun X, Wang X, Li D. Fructose levels are elevated in women with polycystic ovary syndrome with obesity and hyperinsulinemia. Hum Reprod 2020;35:187-194.
  6. Russo E, Leoncini G, Esposito P, Garibotto G, Pontremoli R, Viazzi F. Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age. Int J Mol Sci 2020;21:4479.
  7. Lanaspa MA, Tapia E, Soto V, Sautin Y, Sánchez-Lozada LG. Uric Acid and Fructose: Potential Biological Mechanisms. Semin Nephrol2011;31:426-432.
  8. Johnson RJ, Perez-Pozo SE, Sautin YY, Manitius J, Sanchez-Lozada LG, Feig DI, Shafiu M, Segal M, Glassock RJ, Shimada M, Roncal C, Nakagawa T. Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes? Endocr Rev 2009;30:96-116.
  9. Mumford SL, Dasharathy SS, Pollack AZ, Perkins NJ, Mattison DR, Cole SR, Wactawski-Wende J, Schisterman EF. Serum uric acid in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study. Hum Reprod 2013;28:1853-1862.
  10. Orio F, Palomba S. Reproductive endocrinology: New guidelines for the diagnosis and treatment of PCOS. Nat Rev Endocrinol 2014;10:130-132.
  11. Li D, Liu HX, Fang YY, Huo JN, Wu QJ, Wang TR, Zhou YM, Wang XX, Ma XX. Hyperhomocysteinemia in polycystic ovary syndrome: decreased betaine-homocysteine methyltransferase and cystathionine beta-synthase-mediated homocysteine metabolism. Reprod Biomed Online 2018;37:234-241.
  12. Flegal KM. Body-Mass Index and All-Cause Mortality. Lancet2017;389:2284-2285.
  13. World Health Organization (WHO) International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. WHO Western Pacific Region, Geneva, Switzerland: World Health Organization, 2000.
  14. Friedrich N, Thuesen B, Jørgensen T, Juul A, Spielhagen C, Wallaschofksi H, Linneberg A. The association between IGF-I and insulin resistance: a general population study in Danish adults.Diabetes Care 2012;35:768-773.
  15. Kopin L, Lowenstein C. Dyslipidemia. Ann Intern Med2017;167:ITC81-ITC96.
  16. Na Z, Jiang H, Meng Y, Song J, Feng D, Fang Y, Shi B, Li D. Association of galactose and insulin resistance in polycystic ovary syndrome: A case-control study. EClinicalMedicine2022;47:101379.
  17. Stone C, Koo CY. Additive splines in statistics. In Proceedings of the Statistical Computing Section ASA. Washington, DC, American Statistical Association, 1985.
  18. Salazar MC, Rosen JE, Wang Z, Arnold BN, Thomas DC, Herbst RS, Kim AW, Detterbeck FC, Blasberg JD, Boffa DJ. Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery. JAMA Oncol 2017;3:610-619.
  19. Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med2010;29:1037-1057.
  20. Tan Q, Lv Y, Zhao F, Zhou J, Yang Y, Liu Y, Zhang M, Lu F, Wei Y, Chen X et al. Association of low blood arsenic exposure with level of malondialdehyde among Chinese adults aged 65 and older. Sci Total Environ 2021;758:143638.
  21. de Medeiros SF, Yamamoto MMW, Souto de Medeiros MA, Barbosa BB, Soares JM, Baracat EC. Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age. Endocr Connect 2020;9:74-89.
  22. Taskinen MR, Packard CJ, Borén J. Dietary Fructose and the Metabolic Syndrome. Nutrients 2019;11:1987.
  23. Caliceti C, Calabria D, Roda A, Cicero AFG. Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review.Nutrients 2017;9:395.
  24. Emmerson BT. Effect of oral fructose on urate production. Ann Rheum Dis 1974;33:276-280.
  25. Chang YH, Chiang YF, Chen HY, Huang YJ, Wang KL, Hong YH, Ali M, Shieh TM, Hsia SM. Anti-Inflammatory and Anti-Hyperuricemic Effects of Chrysin on a High Fructose Corn Syrup-Induced Hyperuricemia Rat Model via the Amelioration of Urate Transporters and Inhibition of NLRP3 Inflammasome Signaling Pathway. Antioxidants (Basel)2021;10:564.
  26. Tappy L, Lê KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 2010;90:23-46.
  27. Hu J, Xu W, Yang H, Mu L. Uric acid participating in female reproductive disorders: a review. Reprod Biol Endocrinol2021;19:65.
  28. Lima WG, Martins-Santos ME, Chaves VE. Uric acid as a modulator of glucose and lipid metabolism. Biochimie 2015;116:17-23.
  29. Nakagawa T, Tuttle KR, Short RA, Johnson RJ. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 2005;1:80-86.
  30. Wan X, Xu C, Lin Y, Lu C, Li D, Sang J, He H, Liu X, Li Y, Yu C. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol2016;64:925-932.